| cellular amino acid metabolic process | GO:0006520 | 103 | 0.220 | |
| cytokine production | GO:0001816 | 319 | 0.205 | |
| amine metabolic process | GO:0009308 | 45 | 0.174 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.171 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.166 | |
| regulation of cell activation | GO:0050865 | 289 | 0.144 | |
| t cell differentiation | GO:0030217 | 174 | 0.140 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.133 | |
| heart morphogenesis | GO:0003007 | 178 | 0.131 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.126 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.122 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.120 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.116 | |
| glossopharyngeal nerve morphogenesis | GO:0021615 | 4 | 0.113 | |
| angiogenesis | GO:0001525 | 201 | 0.106 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.104 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.104 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.103 | |
| oxidation reduction process | GO:0055114 | 342 | 0.102 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.099 | |
| muscle tissue development | GO:0060537 | 308 | 0.094 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.092 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.088 | |
| endocrine system development | GO:0035270 | 98 | 0.088 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.087 | |
| gland development | GO:0048732 | 330 | 0.080 | |
| cell fate commitment | GO:0045165 | 210 | 0.079 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.078 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.076 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.076 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.075 | |
| t cell activation | GO:0042110 | 289 | 0.075 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.072 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.072 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.072 | |
| renal system development | GO:0072001 | 225 | 0.071 | |
| blood circulation | GO:0008015 | 195 | 0.070 | |
| cation transport | GO:0006812 | 399 | 0.069 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.068 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.068 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.067 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.067 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.067 | Mouse |
| regulation of secretion | GO:0051046 | 274 | 0.067 | |
| regulation of cell motility | GO:2000145 | 236 | 0.066 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.065 | |
| vegf activated neuropilin signaling pathway | GO:0038190 | 2 | 0.065 | |
| regulation of system process | GO:0044057 | 200 | 0.064 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.064 | |
| regulation of defense response | GO:0031347 | 233 | 0.063 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.062 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.061 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.061 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.061 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.060 | |
| calcium ion transport | GO:0006816 | 159 | 0.059 | |
| ossification | GO:0001503 | 216 | 0.059 | Mouse |
| neural tube formation | GO:0001841 | 108 | 0.058 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.057 | |
| renal tubule development | GO:0061326 | 87 | 0.057 | |
| immune effector process | GO:0002252 | 321 | 0.057 | |
| cellular homeostasis | GO:0019725 | 240 | 0.056 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.056 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.056 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.055 | |
| forebrain development | GO:0030900 | 302 | 0.055 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.055 | |
| cardiac chamber development | GO:0003205 | 108 | 0.054 | |
| developmental maturation | GO:0021700 | 193 | 0.054 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.054 | |
| heart contraction | GO:0060047 | 93 | 0.053 | |
| telencephalon development | GO:0021537 | 186 | 0.053 | |
| myotube differentiation | GO:0014902 | 105 | 0.053 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.052 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.052 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.051 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.051 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.051 | |
| connective tissue development | GO:0061448 | 179 | 0.051 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.051 | |
| steroid metabolic process | GO:0008202 | 119 | 0.050 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.050 | |
| epithelial cell development | GO:0002064 | 159 | 0.050 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.050 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.050 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.050 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.050 | |
| organelle fission | GO:0048285 | 170 | 0.049 | |
| regionalization | GO:0003002 | 337 | 0.049 | Mouse |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.049 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.049 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.049 | |
| muscle cell development | GO:0055001 | 133 | 0.049 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.049 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.049 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.048 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.048 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.048 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.048 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.047 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.047 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.047 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.047 | |
| response to radiation | GO:0009314 | 165 | 0.047 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.047 | |
| striated muscle cell development | GO:0055002 | 125 | 0.047 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.047 | |
| hindbrain development | GO:0030902 | 128 | 0.047 | |
| epidermis development | GO:0008544 | 187 | 0.046 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.046 | |
| regulation of cell migration | GO:0030334 | 219 | 0.046 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.046 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.045 | |
| dna metabolic process | GO:0006259 | 303 | 0.045 | |
| rhombomere 5 development | GO:0021571 | 4 | 0.045 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.045 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.045 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.045 | |
| respiratory tube development | GO:0030323 | 167 | 0.045 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.045 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.044 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.044 | |
| somitogenesis | GO:0001756 | 69 | 0.044 | Mouse |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.044 | |
| response to acid chemical | GO:0001101 | 111 | 0.044 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.044 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.044 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.044 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.043 | |
| hormone metabolic process | GO:0042445 | 86 | 0.043 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.043 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.043 | |
| subpallium neuron fate commitment | GO:0060163 | 2 | 0.043 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.043 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.043 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.042 | |
| germ cell development | GO:0007281 | 185 | 0.042 | |
| regulation of cell migration involved in sprouting angiogenesis | GO:0090049 | 4 | 0.042 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.042 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.042 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.042 | |
| male gamete generation | GO:0048232 | 285 | 0.042 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.042 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.042 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.041 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.041 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.041 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.041 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.041 | |
| inflammatory response | GO:0006954 | 244 | 0.041 | |
| respiratory system development | GO:0060541 | 190 | 0.040 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.040 | |
| metanephric glomerular epithelium development | GO:0072244 | 3 | 0.040 | |
| negative regulation of cardiac chamber morphogenesis | GO:1901220 | 2 | 0.040 | |
| positive regulation of creb transcription factor activity | GO:0032793 | 4 | 0.040 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.040 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.040 | |
| response to growth factor | GO:0070848 | 198 | 0.040 | |
| circulatory system process | GO:0003013 | 197 | 0.040 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.040 | |
| neuropilin signaling pathway | GO:0038189 | 2 | 0.040 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.040 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.040 | |
| mesenchyme development | GO:0060485 | 152 | 0.039 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.039 | |
| nuclear division | GO:0000280 | 158 | 0.039 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.039 | |
| lung development | GO:0030324 | 164 | 0.039 | |
| chemotaxis | GO:0006935 | 247 | 0.039 | |
| chromatin organization | GO:0006325 | 206 | 0.039 | |
| sensory perception | GO:0007600 | 245 | 0.039 | |
| epithelial tube formation | GO:0072175 | 130 | 0.039 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.039 | |
| gonad development | GO:0008406 | 141 | 0.039 | |
| skeletal system development | GO:0001501 | 356 | 0.039 | Mouse |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.038 | |
| cation homeostasis | GO:0055080 | 212 | 0.038 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.038 | |
| neural tube closure | GO:0001843 | 90 | 0.038 | |
| protein secretion | GO:0009306 | 111 | 0.038 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.037 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.037 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.037 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.037 | |
| cytokine secretion | GO:0050663 | 72 | 0.037 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.037 | |
| olfactory bulb development | GO:0021772 | 30 | 0.037 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.037 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.037 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.037 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.036 | |
| cell fate specification | GO:0001708 | 72 | 0.036 | |
| camera type eye development | GO:0043010 | 266 | 0.036 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.036 | |
| response to peptide | GO:1901652 | 136 | 0.036 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.036 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.036 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.036 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.036 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.036 | |
| nephron tubule development | GO:0072080 | 84 | 0.035 | |
| positive regulation of fibroblast growth factor receptor signaling pathway | GO:0045743 | 3 | 0.035 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.035 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.035 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.035 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.035 | |
| b cell activation | GO:0042113 | 161 | 0.035 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.034 | |
| blood vessel remodeling | GO:0001974 | 33 | 0.034 | |
| tube closure | GO:0060606 | 91 | 0.034 | |
| cellular response to lipid | GO:0071396 | 145 | 0.034 | |
| tube formation | GO:0035148 | 140 | 0.034 | |
| mapk cascade | GO:0000165 | 281 | 0.034 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.034 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.034 | |
| kidney epithelium development | GO:0072073 | 121 | 0.033 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.033 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.033 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.033 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.033 | |
| regulation of ion transport | GO:0043269 | 215 | 0.033 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.033 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.033 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.033 | |
| protein maturation | GO:0051604 | 176 | 0.032 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.032 | |
| tissue remodeling | GO:0048771 | 102 | 0.032 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.032 | |
| mesangial cell differentiation | GO:0072007 | 4 | 0.032 | |
| photoreceptor cell differentiation | GO:0046530 | 52 | 0.032 | |
| muscle fiber development | GO:0048747 | 76 | 0.032 | |
| nephron epithelium development | GO:0072009 | 92 | 0.032 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.032 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.032 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.032 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.031 | |
| sinoatrial node cell differentiation | GO:0060921 | 3 | 0.031 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.031 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.031 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.031 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.031 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.031 | |
| limb morphogenesis | GO:0035108 | 149 | 0.031 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.031 | |
| chromatin modification | GO:0016568 | 187 | 0.031 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.030 | |
| metanephric nephron development | GO:0072210 | 34 | 0.030 | |
| neural retina development | GO:0003407 | 41 | 0.030 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 47 | 0.030 | |
| protein ubiquitination | GO:0016567 | 171 | 0.030 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.030 | |
| myotube cell development | GO:0014904 | 60 | 0.030 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.030 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.030 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.030 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.030 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.030 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.030 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.030 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.030 | |
| cartilage development | GO:0051216 | 140 | 0.030 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.029 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.029 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.029 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.029 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.029 | |
| protein localization to organelle | GO:0033365 | 185 | 0.029 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.029 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.029 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.029 | |
| leukocyte migration | GO:0050900 | 124 | 0.029 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.029 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.029 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.029 | |
| fat cell differentiation | GO:0045444 | 160 | 0.029 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.029 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.029 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.028 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.028 | |
| membrane organization | GO:0061024 | 245 | 0.028 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.028 | |
| wound healing | GO:0042060 | 157 | 0.028 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.028 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.028 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.028 | |
| maintenance of location | GO:0051235 | 89 | 0.028 | |
| bundle of his development | GO:0003166 | 4 | 0.028 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.028 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.028 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.028 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.028 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.028 | |
| positive regulation of lymphangiogenesis | GO:1901492 | 3 | 0.027 | |
| embryonic placenta development | GO:0001892 | 98 | 0.027 | |
| histone modification | GO:0016570 | 159 | 0.027 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.027 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.027 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.027 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.027 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.027 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.027 | |
| metanephric glomerular mesangial cell proliferation involved in metanephros development | GO:0072262 | 3 | 0.027 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.027 | |
| eye photoreceptor cell development | GO:0042462 | 31 | 0.027 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.027 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.027 | |
| cell adhesion | GO:0007155 | 329 | 0.027 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.027 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.027 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.027 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.026 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.026 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.026 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.026 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.026 | |
| heart process | GO:0003015 | 94 | 0.026 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.026 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.026 | |
| anion transport | GO:0006820 | 177 | 0.026 | |
| response to nutrient levels | GO:0031667 | 109 | 0.026 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.026 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.026 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.026 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.026 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.026 | |
| positive regulation of secondary heart field cardioblast proliferation | GO:0072513 | 4 | 0.026 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.026 | |
| digestive tract development | GO:0048565 | 190 | 0.026 | |
| diencephalon development | GO:0021536 | 63 | 0.026 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.026 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.026 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.026 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.025 | |
| stem cell differentiation | GO:0048863 | 268 | 0.025 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.025 | |
| limb development | GO:0060173 | 166 | 0.025 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.025 | |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.025 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.025 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.025 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.025 | Mouse |
| regulation of cardiac chamber formation | GO:1901210 | 1 | 0.025 | |
| innate immune response | GO:0045087 | 157 | 0.025 | |
| p38mapk cascade | GO:0038066 | 4 | 0.025 | |
| limbic system development | GO:0021761 | 72 | 0.025 | |
| muscle adaptation | GO:0043500 | 39 | 0.025 | |
| specification of organ position | GO:0010159 | 3 | 0.025 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.025 | |
| positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation | GO:0003257 | 3 | 0.025 | |
| gliogenesis | GO:0042063 | 141 | 0.025 | |
| protein glycosylation | GO:0006486 | 55 | 0.025 | |
| cellular response to peptide | GO:1901653 | 92 | 0.025 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.025 | |
| regulation of protein localization | GO:0032880 | 231 | 0.025 | |
| visceral motor neuron differentiation | GO:0021524 | 3 | 0.025 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.025 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.025 | |
| female sex differentiation | GO:0046660 | 84 | 0.024 | |
| embryonic viscerocranium morphogenesis | GO:0048703 | 8 | 0.024 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.024 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.024 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.024 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.024 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.024 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.024 | |
| regulation of gliogenesis | GO:0014013 | 50 | 0.024 | |
| endocytosis | GO:0006897 | 168 | 0.024 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.024 | |
| male sex differentiation | GO:0046661 | 109 | 0.024 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.024 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.024 | |
| neuron projection guidance | GO:0097485 | 141 | 0.024 | |
| response to fibroblast growth factor | GO:0071774 | 47 | 0.024 | |
| regulation of transcription from rna polymerase ii promoter involved in ventral spinal cord interneuron specification | GO:0021913 | 4 | 0.024 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.024 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.024 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.024 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.024 | |
| positive regulation of production of molecular mediator of immune response | GO:0002702 | 45 | 0.024 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.024 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.024 | |
| neuron migration | GO:0001764 | 122 | 0.024 | |
| body morphogenesis | GO:0010171 | 45 | 0.024 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.023 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.023 | |
| regulation of protein transport | GO:0051223 | 163 | 0.023 | |
| primary neural tube formation | GO:0014020 | 95 | 0.023 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.023 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.023 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.023 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.023 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.023 | |
| interferon gamma production | GO:0032609 | 67 | 0.023 | |
| placenta development | GO:0001890 | 140 | 0.023 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.023 | |
| regulation of organ growth | GO:0046620 | 61 | 0.023 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.023 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.023 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.023 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.023 | |
| protein processing | GO:0016485 | 163 | 0.023 | |
| metencephalon development | GO:0022037 | 89 | 0.023 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.023 | |
| female gonad development | GO:0008585 | 71 | 0.023 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.023 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.023 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.023 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.023 | |
| organ growth | GO:0035265 | 117 | 0.023 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.023 | |
| olfactory lobe development | GO:0021988 | 32 | 0.023 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.023 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.022 | |
| protein o linked glycosylation | GO:0006493 | 16 | 0.022 | |
| ventral spinal cord development | GO:0021517 | 48 | 0.022 | |
| mammary placode formation | GO:0060596 | 4 | 0.022 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.022 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.022 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.022 | |
| t cell proliferation | GO:0042098 | 120 | 0.022 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.022 | |
| glomerular endothelium development | GO:0072011 | 2 | 0.022 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.022 | |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.022 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.022 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.022 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.022 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.022 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.022 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.022 | |
| response to insulin | GO:0032868 | 100 | 0.022 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.022 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.022 | |
| pattern specification involved in metanephros development | GO:0072268 | 4 | 0.022 | |
| somite development | GO:0061053 | 81 | 0.022 | Mouse |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.022 | |
| myoblast differentiation | GO:0045445 | 52 | 0.022 | |
| head morphogenesis | GO:0060323 | 34 | 0.022 | |
| kidney development | GO:0001822 | 213 | 0.022 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.021 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.021 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.021 | |
| heart growth | GO:0060419 | 45 | 0.021 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.021 | |
| lung vasculature development | GO:0060426 | 7 | 0.021 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.021 | |
| metanephric glomerular endothelium development | GO:0072264 | 1 | 0.021 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.021 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.021 | |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.021 | |
| vagus nerve development | GO:0021564 | 3 | 0.021 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.021 | |
| regulation of cardiac chamber morphogenesis | GO:1901219 | 2 | 0.021 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.021 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.021 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.021 | |
| hormone secretion | GO:0046879 | 128 | 0.021 | |
| rhombomere 3 morphogenesis | GO:0021658 | 2 | 0.021 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.021 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.021 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.021 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.021 | |
| cell recognition | GO:0008037 | 83 | 0.021 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.021 | |
| regulation of protein processing | GO:0070613 | 96 | 0.021 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.021 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.021 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.021 | |
| epithelial cell migration | GO:0010631 | 63 | 0.021 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.021 | |
| glomerular mesangial cell proliferation | GO:0072110 | 3 | 0.021 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.020 | |
| stem cell proliferation | GO:0072089 | 117 | 0.020 | |
| thymus development | GO:0048538 | 41 | 0.020 | |
| regulation of tongue muscle cell differentiation | GO:2001035 | 2 | 0.020 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.020 | |
| adaptive immune response | GO:0002250 | 155 | 0.020 | |
| organelle assembly | GO:0070925 | 177 | 0.020 | |
| response to retinoic acid | GO:0032526 | 56 | 0.020 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.020 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.020 | |
| regulation of notch signaling pathway | GO:0008593 | 35 | 0.020 | |
| spermatogenesis | GO:0007283 | 284 | 0.020 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.020 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.020 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.020 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.020 | |
| microtubule based process | GO:0007017 | 236 | 0.020 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.020 | |
| spermatid differentiation | GO:0048515 | 115 | 0.020 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.020 | |
| rhythmic process | GO:0048511 | 174 | 0.020 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.020 | |
| glucose homeostasis | GO:0042593 | 128 | 0.020 | |
| response to steroid hormone | GO:0048545 | 56 | 0.020 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.020 | |
| photoreceptor cell development | GO:0042461 | 40 | 0.020 | |
| epithelium migration | GO:0090132 | 63 | 0.020 | |
| hexose metabolic process | GO:0019318 | 98 | 0.020 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.020 | |
